NCT02095379View on ClinicalTrials.gov

Oligosecretary Myeloma: Prevalence and Its Clinical Significance

CompletedOBSERVATIONAL
Enrollment

390

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Multiple Myeloma
Interventions
OTHER

oligosecretary

not abvailable

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02095379 - Oligosecretary Myeloma: Prevalence and Its Clinical Significance | Biotech Hunter | Biotech Hunter